Narrowing the Gap to Diagnose Alzheimer’s Disease Through Biomarkers

Time: 11:45 am
day: Day One


  • Analyzing several biomarkers to understand their use for neuroinflammation in neurodegenerative diseases
  • Using CSF biomarkers to narrow the gap to diagnostic tests for Alzheimer’s disease
  • Referencing to current human trials of CSF and blood biomarkers to compare the effectivity of blood versus CSF-based biomakers